Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-27 @ 10:06 AM
Study NCT ID:
NCT04825860
Status:
TERMINATED
Last Update Posted:
2024-03-15
First Post:
2021-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
Sponsor:
Sumitomo Pharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-29
First Submit QC Date:
None
Study First Post Date:
2021-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-13
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL